Inhibitors of lipoprotein-associated phospholipase A2

被引：0
|
作者：
Barrett, D
Barlocco, D
机构：
[1] Fujisawa Pharmaceut Co Ltd, Yodogawa Ku, Osaka 5328514, Japan
[2] Univ Milan, I-20131 Milan, Italy
来源：
DRUG DISCOVERY TODAY | 2001年 / 6卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：269 / 270
页数：2
相关论文
共 50 条
  • [21] Overexpression of porcine lipoprotein-associated phospholipase A2 in swine
    Tang, Xiaochun
    Wang, Gangqi
    Liu, Xingxing
    Han, Xiaolei
    Li, Zhuang
    Ran, Guangyao
    Li, Zhanjun
    Song, Qi
    Ji, Yuan
    Wang, Haijun
    Wang, Yuhui
    Ouyang, Hongsheng
    Pang, Daxin
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 465 (03) : 507 - 511
  • [22] The role of lipoprotein-associated phospholipase A2 as a marker for atherosclerosis
    Virani S.S.
    Nambi V.
    Current Atherosclerosis Reports, 2007, 9 (2) : 97 - 103
  • [23] Lipoprotein-associated phospholipase A2 predicts cardiovascular events
    Persson, M
    Nilsson, JA
    Hedblad, B
    Nelson, JJ
    Berglund, G
    CIRCULATION, 2005, 112 (17) : U868 - U868
  • [24] Lipoprotein-associated phospholipase A2: A new therapeutic target
    Lonn, Eva
    CANADIAN JOURNAL OF CARDIOLOGY, 2010, 26 : 27A - 31A
  • [25] Examining the Role of Lipoprotein-Associated Phospholipase A2 in Atherosclerosis
    Gilpatrick, Timothy Edward
    Tomczak, Jonathan
    Bahnson, Brian J.
    FASEB JOURNAL, 2012, 26
  • [26] Advantages of the lipoprotein-associated phospholipase A2 activity assay
    Donato, Leslie J.
    Meeusen, Jeffrey W.
    Callanan, Heidi
    Saenger, Amy K.
    Jaffe, Allan S.
    CLINICAL BIOCHEMISTRY, 2016, 49 (1-2) : 172 - 175
  • [27] Lipoprotein-associated phospholipase A2 and myocardial infarction in women
    Hatoum, Ida J.
    Nelson, Jeanenne J.
    Rexrode, Kathryn
    Manson, Joann
    Rimm, Eric B.
    CIRCULATION, 2007, 116 (16) : 818 - 818
  • [28] Elevated Lipoprotein-Associated Phospholipase A2 Is Associated With Intracranial Atherosclerosis
    Wang, Yuan
    Liu, Gang
    Song, Haiqing
    Cao, Catherine
    Ji, Xunming
    Cao, Guodong
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [29] 1-(Arylpiperazinylamidoalkyl)-pyrimidones:: Orally active inhibitors of lipoprotein-associated phospholipase A2
    Bloomer, JC
    Boyd, HF
    Hickey, DMB
    Ife, RJ
    Leach, CA
    Macphee, CH
    Milliner, KJ
    Pinto, IL
    Rawlings, DA
    Smith, SA
    Stansfield, IG
    Stanway, SJ
    Taylor, MA
    Theobald, CJ
    Whittaker, CM
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (14) : 1925 - 1929
  • [30] Lipoprotein-associated phospholipase A2 levels are elevated in obese children
    Sakka, S.
    Kaminioti, C.
    Pervanidou, P.
    Lazopoulou, N.
    Kanaka-Gantenbein, C.
    Chrousos, G.
    Papassotiriou, I.
    CLINICAL BIOCHEMISTRY, 2011, 44 (07) : 539 - 539
12345